跳至主要内容
临床试验/CTRI/2024/08/072315
CTRI/2024/08/072315尚未招募不适用

Effectiveness of muscle energy technique versus neuro-physiological facilitation technique on pulmonary function and dyspnea among patient with chronic obstructive pulmonary disease

Shradha Gupta1 个研究点 分布在 1 个国家目标入组 64 人开始时间: 2024年9月27日最近更新:
适应症
相关药物

试验速览

阶段
不适用
状态
尚未招募
发起方
入组人数
64
试验地点
1
主要终点
Pulmonary Function Test

研究概览

简要总结

Chronic obstructive pulmonary disease (COPD)is a heterogeneous lung condition characterized by chronic respiratory symptoms (Dyspnea, cough, fatigue and expectoration) leads to limitation in lung airflow. The most typical symptoms of COPD are Dyspnea and fatigue which is debilitating for patients and also associated with a deterioration in their physical activity. A total of 64 patients with COPD based on inclusion criteria will be selected. Patients will be divided into 2 groups (32patients in each) by lottery method. Group A will receive Muscle energy technique and conventional physiotherapy whereas Group B will receive Neuro-physiological facilitation technique combined with conventional physiotherapy. On Day 1 Pulmonary function test (PFT) and Dyspnea-12 questionnaire (D-12) will be used as outcome measures and on the Day 14 Pulmonary function test (PFT) and Dyspnea-12 questionnaire (D-12) will be reassessed**.** The main goal of the treatment is to facilitate excretion of secretions.

研究设计

研究类型
Interventional
分配方式
Coin toss, Lottery, toss of dice, shuffling cards etc
盲法
Participant Blinded

入排标准

年龄范围
40.00 Year(s) 至 80.00 Year(s)(—)

入选标准

  • •Diagnosed cases of COPD.
  • •Both Genders.
  • •Age between 40 to 60 years.
  • •Patient with symptoms of shortness of breath (Dyspnea).
  • •Patient with an exacerbation of COPD.
  • •Value of pulmonary function test below normal value FEV1 greater than equals to more 80% predicted.

排除标准

  • •Individuals suffering from severe spine-related orthopedic issues, neurological disorders impacting the respiratory muscles, unstable cardiac conditions etc.
  • •Patients with no additional disorder such as pneumonia, lung Carcinoma.
  • •Patients with Multidrug Resistant for COPD.
  • •Mentally unstable patients.
  • •Un-cooperative patients.

结局指标

主要结局

Pulmonary Function Test

时间窗: Two point measurements(At Day 1 and At Day 14)

次要结局

  • Dyspnea 12 Questionnaire(Two point measurement (At Day 1 & At Day 14))

研究者

发起方
Shradha Gupta
申办方类型
Other [self]
责任方
Principal Investigator
主要研究者

Shradha Gupta

Maharishi Markandeshwar Medical Collage and Hospital Kumarhatti, Solan

研究点 (1)

Loading locations...

相似试验